H. Soutter

Overview of Recent Progress in Protein-Expression Technologies for Small-Molecule Screening

J. Cuozzo, H. Soutter, 2014, Journal of biomolecular screening.

Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.

David R. Anderson, S. Wright, V. Rao, 2017, Journal of medicinal chemistry.

Structural insight into allosteric modulation of protease-activated receptor 2

Patrik Johansson, Ali Jazayeri, Christoph Grebner, 2017, Nature.

Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors.

Anthony D. Keefe, Christoph E. Dumelin, S. Kazmirski, 2017, ACS medicinal chemistry letters.

Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.

Allan Wissner, Nicole Caspers, R. Kurumbail, 2011, Bioorganic & medicinal chemistry letters.

Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA‐Encoded Chemical Library

Diana Gikunju, Anthony D. Keefe, Ying Zhang, 2017, Chembiochem : a European journal of chemical biology.

Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action

Christoph E. Dumelin, A. Keefe, O. Fedorov, 2017, ACS chemical biology.

Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology

Christoph E. Dumelin, A. Keefe, J. Breed, 2016, Proceedings of the National Academy of Sciences.

Fragment‐Based Screen against HIV Protease

J. E. Elder, A. Olson, D. McRee, 2010, Chemical biology & drug design.